People with obesity often suffer from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are also known to change the activity of CYP enzymes [4•]. This evidence concerns the gene PPIG and metabolic dysfunction-associated steatotic liver disease.